Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154668 | SCV000204345 | benign | not specified | 2012-02-02 | criteria provided, single submitter | clinical testing | Inferred frequency = 141/386 (LMM data) |
ARUP Laboratories, |
RCV001515001 | SCV001158871 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001515001 | SCV001722982 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001533662 | SCV001750414 | benign | Usher syndrome type 2A | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154668 | SCV003928758 | benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888599 | SCV004708008 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV001515001 | SCV005280601 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000154668 | SCV001743749 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000154668 | SCV001970425 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001533662 | SCV002093899 | benign | Usher syndrome type 2A | 2019-11-18 | no assertion criteria provided | clinical testing |